GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellid Co Ltd (XKRX:299660) » Definitions » Interest Expense

Cellid Co (XKRX:299660) Interest Expense : ₩-472 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cellid Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cellid Co's interest expense for the three months ended in Dec. 2024 was ₩ -3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-472 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cellid Co's Operating Income for the three months ended in Dec. 2024 was ₩ -3,605 Mil. Cellid Co's Interest Expense for the three months ended in Dec. 2024 was ₩ -3 Mil. Cellid Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Cellid Co Interest Expense Historical Data

The historical data trend for Cellid Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellid Co Interest Expense Chart

Cellid Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only -12.55 -536.29 -1,628.29 -1,264.47 -471.96

Cellid Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -286.57 -306.70 -85.56 -77.07 -2.63

Cellid Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-472 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cellid Co  (XKRX:299660) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cellid Co's Interest Expense for the three months ended in Dec. 2024 was ₩-3 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩-3,605 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₩13,118 Mil.

Cellid Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Cellid Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Cellid Co Business Description

Traded in Other Exchanges
N/A
Address
1 Gwanak-ro, Gwanak-gu, 142 Suite 504, Korea Seoul National University Building, seoul, KOR, 08826
Cellid Co Ltd is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.

Cellid Co Headlines

No Headlines